Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
N-CONTAINING HETEROCYCLIC COMPOUND
Document Type and Number:
Japanese Patent JP2016006113
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To design and/or identify compounds which specifically inhibit kinases of JAK and Aurora family, especially compounds which may preferentially inhibit one or more of JAK kinases compared with other JAK kinases.SOLUTION: The invention relates to an N-containing heterocyclic compound which is an inhibitor of protein kinases including JAK kinases. More specifically, the compounds are selective to JAK1, JAK2, JAK3 or TYK2 kinases and combinations thereof (for example, a combination of JAK1 and JAK2 and the like). These kinase inhibitors can be used for treatments of kinase related diseases, for example immunological and inflammatory diseases including organ transplantation; hyperproliferative diseases including cancer and myeloproliferative diseases; virus diseases; metabolic diseases; and vascular diseases and the like.

Inventors:
DAVID GERARD BOURKE
BURNS CHRISTOPHER JOHN
ANTHONY NICHOLAS CUZZUPE
JOHN THOMAS FEUTRILL
MARCEL ROBERT KLING
TRACY LEAH NERO
Application Number:
JP2015171850A
Publication Date:
January 14, 2016
Filing Date:
September 01, 2015
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
YM BIOSCIENCES AUSTRALIA PTY
International Classes:
C07D487/04; A61K31/519; A61K31/5377; A61P3/00; A61P9/00; A61P29/00; A61P31/12; A61P35/00; A61P37/02; A61P43/00; C07D495/04
Domestic Patent References:
JP2005523251A2005-08-04
JP2005523251A2005-08-04
Foreign References:
WO2003055890A12003-07-10
US20070142402A12007-06-21
WO2003055890A12003-07-10
US20070142402A12007-06-21
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mitsuhiro
Tatsuhiko Abe